Evidence map›Paper›PMID 23084278›Full record

ArticleBioorganic & medicinal chemistry letters2012

Structure-activity relationship exploration of Kv1.3 blockers based on diphenoxylate.

William Nguyen, Brittany L Howard, David P Jenkins, Heike Wulff, Philip E Thompson, David T Manallack

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 11 citations in OpenAlex.

  1. Discovery of KMedicinal research reviews · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

William NguyenMedicinal Chemistry and Drug Action, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Vic. 3052, Australia.
Brittany L Howard
David P Jenkins
Heike Wulff
Philip E Thompson
David T Manallack
Monash University · AUUniversity of California, Davis · US

Funding

The microglial potassium channels Kv1.3 and KCa3.1 as therapeutic targets for neuR01GM076063 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI WULFF, HEIKE · 2006 to 2014
$2.5M
NIGMS NIH HHS R01 GM076063
6 · The paper itself

Abstract

Diphenoxylate, a well-known opioid agonist and anti-diarrhoeal agent, was recently found to block Kv1.3 potassium channels, which have been proposed as potential therapeutic targets for a range of autoimmune diseases. The molecular basis for this Kv1.3 blockade was assessed by the selective removal of functional groups from the structure of diphenoxylate as well as a number of other structural variations. Removal of the nitrile functional group and replacement of the C-4 piperidinyl substituents resulted in several compounds with submicromolar IC(50) values.

Indexed as

DiphenoxylateHumansKineticsKv1.3 Potassium ChannelPotassium Channel BlockersProtein BindingStructure-Activity RelationshipDiphenoxylateKv1.3 Potassium ChannelPotassium Channel Blockers

Identifiers

PMID23084278
PMCPMC3664202
OpenAlexW1991274763

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.